Navigation Links
GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
Date:6/5/2008

ANN ARBOR, Mich., June 5 /PRNewswire/ -- Compendia Bioscience today announced that it has signed a two-year licensing agreement with GlaxoSmithKline (NYSE: GSK) for Oncomine(TM) Enterprise Edition, a value-added product extension Compendia's flagship product, Oncomine. Oncomine Enterprise Edition builds upon the features of Oncomine Professional and Concepts editions by integrating the ability to securely view proprietary gene expression data in comparison with existing public data already available in Oncomine.

Oncomine is a rapidly growing compendium of nearly 26,000 gene expression and DNA copy number profiles collected and curated from the literature and other public sources. These data are coupled with analysis functions and a web application for data mining and visualization. Oncomine Concepts Map, licensed to commercial users as part of the Oncomine Enterprise Edition, uses gene sets as a common language to compare and link disparate biological concepts, allowing researchers to discover and explore new biology based on signatures related to drugs and/or disease pathways.

"We are pleased to welcome GlaxoSmithKline to our growing list of major pharmaceutical and biotech customers," said John Freshley, Chief Business Officer of Compendia Bioscience. "GSK has long been a leader in the field of cancer genomics and we look forward to working closely with them to advance their oncology discovery and development efforts."

About Compendia Bioscience, Inc.

Compendia Bioscience is dedicated to harnessing the global collection of high throughput molecular data to provide researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, a
'/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
7. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
8. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
9. GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
10. Vaccinex Antibody Licensed to GlaxoSmithKline
11. Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Michael R. Drapp, a 34-year ...d nanoEdge™ Technologies, a business develop...focused on the emerging nanotechnology space. The...ogies and act as a nanotechnology incubator. , ...r 1, 2009 -- Michael R. Drapp , a 34-year veteran...
(Date:11/30/2009)...Cambridge, Mass November 30, 2009 An internation...tsu Photonics, and ETH Zrich have demonstrated com...ing in the invisible part of the light spectrum (i...e light beam of a well-defined wavelength. The inn...lications related to remote chemical sensing pollu...
(Date:11/30/2009)... , BLOOMINGTON, Minn., Nov. 30 /PRNewswire/ -...e medical image management software, data migratio...with Allina Hospitals and Clinics for a new Vendor...f image storage across the Allina network of hospi...solution is based on the Acuo Technologies DICOM S...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-First...-stage vaccine company, announced today that the c...h Care Conference 2009 on December 2, 2009 at 12:3... Novavax will provide an overview of the company,s...ess and upcoming milestones. A link to the live a...
Breaking Biology Technology:Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Scientists demonstrate multibeam, multi-functional lasers 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...aceuticals,Inc. (Nasdaq: ARNA ) announced today t...ts with Siegfried Ltd., an affiliate of Siegfried,...elate to the,manufacturing of lorcaserin hydrochlo...s planned New Drug Application (NDA) submission to...or commercialization of,lorcaserin after regulator...
...technology could eliminate animal testing in the c... curtail its use in the development of new pharmac... researchers at Rensselaer Polytechnic Institute, ...dus Biosciences Inc. , The team,s most recent di...on of the Proceedings of the National Academy of S...
... IRIDEX,Corporation (Nasdaq: IRIX ) today announc...ny as Chief Financial Officer effective January 2,...l Officer and Vice President,of Finance for NextHo...logy,company. Previously, he served as Vice Presid...oGear Technology Corp., a company that developed,a...
Other Biology Technology:Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin 2Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin 3Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin 4Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin 5Biochip mimics the body to reveal toxicity of industrial compounds 2Biochip mimics the body to reveal toxicity of industrial compounds 3IRIDEX Announces James Mackaness Will Be Chief Financial Officer 2
(Date:11/30/2009)...er thought the stress of seeing your extended fami...s: a new research report in the December 2009 prin...tp://www.jleukbio.org ) shows that you might be ri...tudy might lead to entirely new treatments that he... and eczema under control. That,s because research...
(Date:11/30/2009)...s a colorless and odorless radioactive gas that is...um is a product of uranium decay and is found in t... and groundwater as well as building materials, pl...entration is expressed as the amount of radiation ...cts in a liter of air; thus the units are picocuri...
(Date:11/26/2009)...s have at last worked out a way of using recording...rd populations. This is the first time sound recor... into accurate estimates of bird species, populati...itish Ecological Society,s Journal of Applied Eco...ad to a major advance in our ability to monitor wh...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Ecologists sound out new solution for monitoring cryptic species 2Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 1Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 2Psoriasis Raises Risk of Heart Attack Stroke Death 48954 1Psoriasis Raises Risk of Heart Attack Stroke Death 48954 2MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 1MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 2
...ub-Saharan Africa, according to the World Health O...nst the virus have achieved limited success. But w...ted infection found widely in that region of Afric...ould reduce transmission of HIV as much as 10-fold... from the University of North Carolina at Chapel H...
...era enables shorter image acquisition times, provi... diagnostic procedures using simultaneous multi-is...onize functional imaging, according to results rel...Diego. , "The potential of using more than one tr...s that more than one medical condition can be sear...
...lls of the immune system has been discovered at Th...nowledge, medical researchers can begin to conside...sing this new cell to target specific infections s... and even autoimmune diseases. , Dendritic cells (...atrol the body, searching for infections. DC seize...
Other Biology News:Vaccine shown effective against chancroid 2Vaccine shown effective against chancroid 3Patients to benefit from novel technology revolutionizing high-speed molecular imaging 2Patients to benefit from novel technology revolutionizing high-speed molecular imaging 3Knowledge of dendritic cells branches out 2
Goat Anti-Human Serpin B5 / Maspin Polyclonal Antibody, Unconjugated from R&D Systems
...29 cm, 1. One system for gel staining and blot pr...ilver-stain gels for proteins and nucleic acid ana...ection and chromogenic detection. Programmable con... time.Proven design for consistent, high-quality p...
...SDA Research Registered OLAW Assured AAALAC Accred...LAS Certified Technicians Documentation GLP Proc...est Focus CRP is your one stop shopping point fo...fer free project consultation, free peptide sequen...
..., FHS-LVF, and the CVD-Diffuse We've combined our...ilters to create the world's first notch filter wi...bandpass. Each filter features an excellent transm...se filters -- with interference coatings applied t...
Biology Products: